This is a prospective, randomized, single center, phase 4 controlled trial. The study will compare the efficacy of two different strategies for the management of predicted poor response patients under stimulation for IVF/ICSI: up to three MNC cycles (group 1) versus a single GnRH antagonist CFA (group 2).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
208
CFA will be administered in combination with Follitropin beta.
Follitropin beta in a low dose will be given.
University Hospital Ghent
Ghent, Belgium
RECRUITINGNumber of good quality blastocysts after CFA stimulation vs. after a first MNC
Time frame: On fifth day of embryonal development
Number of good quality blastocysts after CFA stimulation vs. after a second or third MNC
Time frame: On fifth day of embryonal development
The relative number of blastocysts after ART, relative to the number of oocytes
Time frame: On fifth day of embryonal development
The probability of having at least one blastocyst of good quality after ART
Time frame: On fifth day of embryonal development
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.